(1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ACTN4 mRNA CTD PMID:36331819 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACTN4 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:735302 6480464 Estradiol results in increased expression of ACTN4 mRNA CTD PMID:31614463 2,2,2-tetramine multiple interactions ISO RGD:61816 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of ACTN4 protein] CTD PMID:19634143 2,3',4,4',5-Pentachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACTN4 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:61816 6480464 Tetrachlorodibenzodioxin results in increased expression of ACTN4 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ACTN4 mRNA CTD PMID:20702594 , PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran affects expression EXP 6480464 2 more ... CTD PMID:20702594 2,6-dinitrotoluene affects expression ISO RGD:61816 6480464 2, 6-dinitrotoluene affects the expression of ACTN4 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:735302 6480464 beta-methylcholine affects the expression of ACTN4 mRNA CTD PMID:21179406 2-nitrotoluene decreases expression ISO RGD:61816 6480464 2-nitrotoluene results in decreased expression of ACTN4 mRNA CTD PMID:16460773 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:61816 6480464 3 more ... CTD PMID:23196670 3-chloropropane-1,2-diol increases expression ISO RGD:61816 6480464 alpha-Chlorohydrin results in increased expression of ACTN4 protein CTD PMID:26597043 4,4'-sulfonyldiphenol multiple interactions ISO RGD:61816 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ACTN4 mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol increases expression ISO RGD:735302 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ACTN4 protein CTD PMID:34186270 4-hydroxynon-2-enal affects binding ISO RGD:735302 6480464 ACTN4 protein binds to 4-hydroxy-2-nonenal CTD PMID:20043646 7,12-dimethyltetraphene increases expression ISO RGD:61816 6480464 9 more ... CTD PMID:12376462 aflatoxin B1 decreases expression ISO RGD:735302 6480464 Aflatoxin B1 results in decreased expression of ACTN4 mRNA CTD PMID:22100608 aflatoxin B1 increases methylation ISO RGD:735302 6480464 Aflatoxin B1 results in increased methylation of ACTN4 intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO RGD:735302 6480464 aflatoxin B2 results in increased methylation of ACTN4 intron CTD PMID:30157460 ammonium chloride affects expression ISO RGD:61816 6480464 Ammonium Chloride affects the expression of ACTN4 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:735302 6480464 Antirheumatic Agents results in increased expression of ACTN4 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:735302 6480464 aristolochic acid I results in increased expression of ACTN4 protein CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:735302 6480464 arsenite promotes the reaction [G3BP1 protein binds to ACTN4 protein] CTD PMID:32406909 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of ACTN4 intron CTD PMID:27901495 bisphenol A increases expression ISO RGD:61816 6480464 bisphenol A results in increased expression of ACTN4 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:735302 6480464 bisphenol A results in increased expression of ACTN4 protein CTD PMID:34186270 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ACTN4 mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO RGD:61816 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ACTN4 mRNA CTD PMID:36041667 bisphenol A multiple interactions ISO RGD:735302 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ACTN4 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ACTN4 mRNA, bisphenol A results in decreased expression of ACTN4 protein CTD PMID:33221593 , PMID:35999755 bisphenol A decreases methylation ISO RGD:735302 6480464 bisphenol A results in decreased methylation of ACTN4 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:61816 6480464 bisphenol A results in decreased expression of ACTN4 mRNA CTD PMID:34947998 bisphenol A affects expression ISO RGD:735302 6480464 bisphenol A affects the expression of ACTN4 mRNA CTD PMID:30903817 bisphenol A affects expression ISO RGD:61816 6480464 bisphenol A affects the expression of ACTN4 mRNA CTD PMID:30816183 Bisphenol B increases expression ISO RGD:735302 6480464 bisphenol B results in increased expression of ACTN4 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:61816 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ACTN4 mRNA CTD PMID:36041667 bleomycin A2 decreases expression ISO RGD:61816 6480464 Bleomycin results in decreased expression of ACTN4 protein CTD PMID:25933445 bromobenzene decreases expression ISO RGD:61816 6480464 bromobenzene results in decreased expression of ACTN4 mRNA CTD PMID:15056800 bromochloroacetic acid decreases expression ISO RGD:61816 6480464 bromochloroacetic acid results in decreased expression of ACTN4 mRNA CTD PMID:16460773 butan-1-ol multiple interactions ISO RGD:735302 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ACTN4 mRNA CTD PMID:29432896 C60 fullerene decreases expression ISO RGD:61816 6480464 fullerene C60 results in decreased expression of ACTN4 mRNA CTD PMID:19167457 caffeine decreases phosphorylation ISO RGD:735302 6480464 Caffeine results in decreased phosphorylation of ACTN4 protein CTD PMID:35688186 carbonyl sulfide increases expression ISO RGD:61816 6480464 carbonyl sulfide results in increased expression of ACTN4 mRNA CTD PMID:19395590 carvedilol decreases expression ISO RGD:61816 6480464 carvedilol results in decreased expression of ACTN4 protein CTD PMID:20403466 CGP 52608 multiple interactions ISO RGD:735302 6480464 CGP 52608 promotes the reaction [RORA protein binds to ACTN4 gene] CTD PMID:28238834 chlordecone decreases expression EXP 6480464 Chlordecone results in decreased expression of ACTN4 mRNA CTD PMID:33711761 chloropicrin increases expression ISO RGD:735302 6480464 chloropicrin results in increased expression of ACTN4 mRNA CTD PMID:26352163 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of ACTN4 mRNA CTD PMID:37019170 cobalt dichloride decreases expression ISO RGD:735302 6480464 cobaltous chloride results in decreased expression of ACTN4 mRNA CTD PMID:19320972 crocidolite asbestos increases expression ISO RGD:735302 6480464 Asbestos, Crocidolite results in increased expression of ACTN4 protein CTD PMID:29553831 CU-O LINKAGE increases expression ISO RGD:735302 6480464 cupric oxide results in increased expression of ACTN4 protein CTD PMID:25470785 cyclosporin A decreases expression ISO RGD:735302 6480464 Cyclosporine results in decreased expression of ACTN4 mRNA CTD PMID:20106945 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ACTN4 mRNA CTD PMID:17361019 , PMID:21266533 diuron decreases expression ISO RGD:735302 6480464 Diuron results in decreased expression of ACTN4 mRNA CTD PMID:35967413 doxorubicin affects localization ISO RGD:61816 6480464 Doxorubicin affects the localization of ACTN4 protein CTD PMID:16636307 doxorubicin increases expression ISO RGD:735302 6480464 Doxorubicin results in increased expression of ACTN4 mRNA CTD PMID:29803840 elemental selenium increases expression ISO RGD:735302 6480464 Selenium results in increased expression of ACTN4 mRNA CTD PMID:19244175 endosulfan decreases expression ISO RGD:61816 6480464 Endosulfan results in decreased expression of ACTN4 mRNA CTD PMID:31464424 enzyme inhibitor multiple interactions ISO RGD:735302 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ACTN4 protein CTD PMID:23301498 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of ACTN4 mRNA CTD PMID:35436446 ethanol decreases expression ISO RGD:61816 6480464 Ethanol results in decreased expression of ACTN4 protein CTD PMID:26185205 fenthion increases expression EXP 6480464 Fenthion results in increased expression of ACTN4 mRNA CTD PMID:34813904 finasteride increases expression ISO RGD:61816 6480464 Finasteride results in increased expression of ACTN4 mRNA CTD PMID:24136188 flavonoids decreases expression ISO RGD:61816 6480464 Flavonoids results in decreased expression of ACTN4 mRNA CTD PMID:18035473 fulvestrant multiple interactions ISO RGD:735302 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ACTN4 gene CTD PMID:31601247 gentamycin increases expression ISO RGD:61816 6480464 Gentamicins results in increased expression of ACTN4 mRNA CTD PMID:33387578 hydrazine increases expression EXP 6480464 hydrazine results in increased expression of ACTN4 mRNA CTD PMID:15282401 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ACTN4 mRNA CTD PMID:36331819 ivermectin decreases expression ISO RGD:735302 6480464 Ivermectin results in decreased expression of ACTN4 protein CTD PMID:32959892 methidathion increases expression EXP 6480464 methidathion results in increased expression of ACTN4 mRNA CTD PMID:34813904 methoxychlor affects methylation ISO RGD:61816 6480464 Methoxychlor affects the methylation of ACTN4 gene CTD PMID:35440735 N-ethyl-N-nitrosourea increases expression ISO RGD:61816 6480464 Ethylnitrosourea results in increased expression of ACTN4 mRNA CTD PMID:15954086 N-nitrosomorpholine decreases expression ISO RGD:61816 6480464 N-nitrosomorpholine results in decreased expression of ACTN4 protein CTD PMID:19716841 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of ACTN4 mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ACTN4 mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ACTN4 mRNA CTD PMID:36331819 PhIP increases expression ISO RGD:61816 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of ACTN4 mRNA CTD PMID:12376462 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ACTN4 mRNA CTD PMID:23811191 prostaglandin A1 increases metabolic processing EXP 6480464 prostaglandin A1 analog results in increased metabolism of ACTN4 protein CTD PMID:19800325 quercitrin affects expression ISO RGD:735302 6480464 quercitrin affects the expression of ACTN4 mRNA CTD PMID:25193878 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of ACTN4 protein CTD PMID:25505154 selenium atom increases expression ISO RGD:735302 6480464 Selenium results in increased expression of ACTN4 mRNA CTD PMID:19244175 silicon dioxide affects secretion ISO RGD:735302 6480464 Silicon Dioxide analog affects the secretion of ACTN4 protein CTD PMID:25895662 simvastatin increases expression ISO RGD:735302 6480464 Simvastatin results in increased expression of ACTN4 mRNA CTD PMID:16710349 sodium arsenite decreases expression ISO RGD:735302 6480464 sodium arsenite results in decreased expression of ACTN4 mRNA CTD PMID:34032870 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ACTN4 mRNA CTD PMID:36209798 streptozocin increases expression ISO RGD:61816 6480464 Streptozocin results in increased expression of ACTN4 protein CTD PMID:19634143 streptozocin multiple interactions ISO RGD:61816 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of ACTN4 protein] CTD PMID:19634143 sunitinib decreases expression ISO RGD:735302 6480464 Sunitinib results in decreased expression of ACTN4 mRNA CTD PMID:31533062 temozolomide decreases expression ISO RGD:735302 6480464 Temozolomide results in decreased expression of ACTN4 mRNA CTD PMID:31758290 testosterone increases expression EXP 6480464 Testosterone deficiency results in increased expression of ACTN4 mRNA CTD PMID:33848595 testosterone multiple interactions EXP 6480464 1 more ... CTD PMID:33848595 thapsigargin decreases expression ISO RGD:61816 6480464 Thapsigargin results in decreased expression of ACTN4 protein CTD PMID:35544339 triptonide decreases expression EXP 6480464 triptonide results in decreased expression of ACTN4 mRNA CTD PMID:33045310 tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of ACTN4 mRNA CTD PMID:30912803 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of ACTN4 mRNA CTD PMID:17292431 valproic acid decreases expression ISO RGD:735302 6480464 Valproic Acid results in decreased expression of ACTN4 mRNA CTD PMID:29154799 vinclozolin increases expression ISO RGD:61816 6480464 vinclozolin results in increased expression of ACTN4 mRNA CTD PMID:22570695 vitamin E increases expression ISO RGD:735302 6480464 Vitamin E results in increased expression of ACTN4 mRNA CTD PMID:19244175 zoledronic acid decreases expression ISO RGD:735302 6480464 zoledronic acid results in decreased expression of ACTN4 protein CTD PMID:28871336